Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PYRAZINAMIDE Cause Interstitial lung disease? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with PYRAZINAMIDE (Pyrazinamide). This represents 0.1% of all adverse event reports for PYRAZINAMIDE.

6
Reports of Interstitial lung disease with PYRAZINAMIDE
0.1%
of all PYRAZINAMIDE reports
2
Deaths
2
Hospitalizations

How Dangerous Is Interstitial lung disease From PYRAZINAMIDE?

Of the 6 reports, 2 (33.3%) resulted in death, 2 (33.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PYRAZINAMIDE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does PYRAZINAMIDE Cause?

Drug-induced liver injury (588) Drug reaction with eosinophilia and systemic symptoms (492) Paradoxical drug reaction (407) Vomiting (307) Pyrexia (301) Drug ineffective (298) Off label use (288) Hepatotoxicity (279) Drug resistance (269) Nausea (251)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which PYRAZINAMIDE Alternatives Have Lower Interstitial lung disease Risk?

PYRAZINAMIDE vs PYRIDOSTIGMINE PYRAZINAMIDE vs PYRIDOXINE PYRAZINAMIDE vs PYRIDOXINE\THIAMINE PYRAZINAMIDE vs PYRIMETHAMINE PYRAZINAMIDE vs PYROTINIB

Related Pages

PYRAZINAMIDE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease PYRAZINAMIDE Demographics